All In MedTech

Device Trial Radar · NCT04945824

A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects

An Open-label, Multi-center, Bilateral, Human Factors Study to Evaluate the Utilization and Safety of a Novel Intracanalicular Insertion Device in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Feb 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

2

Actual

Start

Jun 1, 2021

Primary completion

Nov 1, 2022

Study completion Nov 1, 2022

Sponsor

Lead sponsor
Ocular Therapeutix, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 30, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is an open-label, multi-center, bilateral, human factors study designed to evaluate the utilization and safety of a novel intracanalicular insertion device in healthy subjects and to evaluate the concentration of DEXTENZA in tears. Each subject's participation is expected to last for approximately 1 month from the DEXTENZA insertion.

Conditions

  • Healthy

Interventions

  • Dexamethasone OphthalmicDrug

    Insertion Device: A handheld mechanical device used by the clinician to dilate the punctum and deliver the DEXTENZA insert into the canaliculus; designed to be single-use and pre-loaded with a single DEXTENZA insert.

  • DilatorDevice

    Intracanalicular Dilator Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ease of insertion as assessed by Post-Insertion Investigator QuestionnaireTime frame: Assessed at Visit 1 (Day 1)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ocular Therapeutix, Inc.

    Sioux Falls, South Dakota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.